CIMZIA® is used to treat several conditions such as Crohn’s disease, rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and non-radiographic axial spondyloarthritis in certain patients. It is a biologic drug in the class of drugs called anti-TNFs or TNF blockers because it reduces and improves symptoms by blocking a protein called TNFa (tumor necrosis factor alpha). This prescription drug should only be obtained through reliable suppliers, so be careful where your buy CIMZIA®. CIMZIA® first received FDA approval in 2008 for moderate to severe active Crohn’s disease in adults who have an inadequate response to to reduce signs and symptoms. Since then, it has also been approved for specific adult patients with other conditions.